Young E. Park

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Journal: Neurology

Published: May 15, 2026

Comparison of hemoglobin variability between short- and intermediate-acting erythropoiesis-stimulating agents: a retrospective cohort study.

Comparison of hemoglobin variability between short- and intermediate-acting erythropoiesis-stimulating agents: a retrospective cohort study.

Journal: Journal of Yeungnam medical science

Published: April 24, 2026

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Journal: Neurology

Published: March 12, 2026

High-content screening morphological analysis to evaluate hepatic apoptosis induced by plant alkaloids in a Chang cell model.

High-content screening morphological analysis to evaluate hepatic apoptosis induced by plant alkaloids in a Chang cell model.

Journal: Toxicology

Published: February 07, 2025

Machine learning prediction model of the treatment response in schizophrenia reveals the importance of metabolic and subjective characteristics.

Machine learning prediction model of the treatment response in schizophrenia reveals the importance of metabolic and subjective characteristics.

Journal: Schizophrenia research

Published: May 28, 2024

AI recommendation vs. crowdsourced recommendation vs. travel expert recommendation: The moderating role of consumption goal on travel destination decision.

AI recommendation vs. crowdsourced recommendation vs. travel expert recommendation: The moderating role of consumption goal on travel destination decision.

Journal: PloS one

Published: February 07, 2024

Experimental pretreatment with YES-10®, a plant extract rich in scutellarin and chlorogenic acid, protects hippocampal neurons from ischemia/reperfusion injury via antioxidant role.

Experimental pretreatment with YES-10®, a plant extract rich in scutellarin and chlorogenic acid, protects hippocampal neurons from ischemia/reperfusion injury via antioxidant role.

Journal: Experimental and therapeutic medicine

Published: July 18, 2020

Erratum to: Progression of GNE Myopathy Based on the Patient-Reported Outcome.

Erratum to: Progression of GNE Myopathy Based on the Patient-Reported Outcome.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: July 14, 2020

A Case of Myositis Preceding Neuropathy in Eosinophilic Granulomatosis with Polyangiitis.

A Case of Myositis Preceding Neuropathy in Eosinophilic Granulomatosis with Polyangiitis.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: July 07, 2020

Comparison of neuronal death and expression of TNF‑α and MCT4 in the gerbil hippocampal CA1 region induced by ischemia/reperfusion under hyperthermia to those under normothermia.

Comparison of neuronal death and expression of TNF‑α and MCT4 in the gerbil hippocampal CA1 region induced by ischemia/reperfusion under hyperthermia to those under normothermia.

Journal: Molecular medicine reports

Published: February 12, 2020

YES-10, A Combination of Extracts from Clematis mandshurica RUPR. and Erigeron annuus (L.) PERS., Prevents Ischemic Brain Injury in A Gerbil Model of Transient Forebrain Ischemia.

YES-10, A Combination of Extracts from Clematis mandshurica RUPR. and Erigeron annuus (L.) PERS., Prevents Ischemic Brain Injury in A Gerbil Model of Transient Forebrain Ischemia.

Journal: Plants (Basel, Switzerland)

Published: December 14, 2019

Post-treatment with oxcarbazepine confers potent neuroprotection against transient global cerebral ischemic injury by activating Nrf2 defense pathway.

Post-treatment with oxcarbazepine confers potent neuroprotection against transient global cerebral ischemic injury by activating Nrf2 defense pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 27, 2019

Showing 1-12 of 42

Last Updated: 09/26/2026